Jamie Dimon's cancer sparks successor question
July 02, 2014 at 09:25 AM EDT
While Jamie Dimon's prognosis for recovery is good, JPMorgan's board needs to think about his successor, says Yale professor Jeffrey Sonnenfeld.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.